Can a Brain Scan Diagnose ADHD? Not Yet.


For an adult who has spent years wondering why ordinary responsibilities require extraordinary effort, the idea of a brain scan that could finally explain things is understandably appealing. An image can seem more definitive than a history of missed deadlines, elaborate coping systems, or exhaustion behind otherwise strong performance. But identifying brain patterns associated with ADHD is not the same as developing a scan that can diagnose it.
A study reported in Nature Mental Health explores that distinction. Researchers analyzed genetic data and multiple types of MRI measurements from 6,001 participants in the Adolescent Brain Cognitive Development cohort. They identified patterns of brain activity and gray-matter volume associated with ADHD polygenic risk, a measure combining many genetic variants associated with susceptibility to ADHD.
The reported patterns involved cognitive-control networks and midbrain regions implicated in dopamine signaling. They were reproducible across ancestry- and sex-defined groups, and external testing using ADHD-200 data linked the patterns to measures of inattention and hyperactivity. The large imaging sample and replication strategy make this more informative than an isolated finding from a small group.
There is, however, an essential qualification: the main cohort consisted of children and adolescents, not adults.
A biological association is not a diagnostic test
This research contributes to understanding ADHD as a neurodevelopmental condition involving distributed brain systems. It does not establish a single “ADHD brain,” directly measure a dopamine deficiency, or show that the identified brain patterns cause symptoms. Genetic risk is also not genetic destiny.
A finding can be reproducible across groups without being accurate enough to guide an individual diagnosis. Clinical usefulness requires more than detecting an association: a test must reliably distinguish the condition from relevant alternatives, work in the people who will actually receive it, and add useful information to existing assessment. This study does not establish that an MRI can confirm or exclude ADHD in an adult.
The replication findings deserve attention, but they do not remove every uncertainty. Polygenic scores capture only part of susceptibility, and their performance may vary across populations. Results from developing brains cannot simply be assumed to apply to adults with decades of experience, treatment, and compensatory strategies.
What this means for adults who appear to be doing well
For accomplished adults, the most useful question is not whether their brain resembles an image in a research paper. It is whether their developmental history, persistent symptoms, and difficulties across settings support ADHD, while accounting for other possible explanations. Sleep problems, mood symptoms, anxiety, and other contributors still need careful consideration.
Professional achievement does not settle that question. Assessment needs room for both what someone accomplishes and what it takes to accomplish it: extensive external structure, repeated last-minute work, neglected responsibilities outside work, or difficulty sustaining routines. These experiences need exploration, not automatic attribution to ADHD or dismissal because a person is successful.
A scan is not required to make someone’s difficulties legitimate. Equally, a compelling image should not substitute for the work of understanding those difficulties accurately.
The value of this research is that it may sharpen our understanding of ADHD biology. That is meaningful progress, even when it does not produce a clinical test. For now, the distinction worth preserving is straightforward: evidence about a condition is not automatically a diagnostic answer for a person.
Research referenced
ADHD polygenic risk converges on reproducible neuroimaging signatures predicting core behavioral phenotypes. Nature Mental Health. October 9, 2026. DOI: 10.1038/s44220-026-00720-7.




Comments